Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents

Dermatology

Volumn 205, Issue 4, 2002, Pages 329-339

  Kasraee, Behrooz ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cysteaminylphenol; Depigmentation; Glucocorticoids; Hydroquinone; Melanocytotoxicity; Melanogenesis; Methimazole; Nordimaprit; Peroxidase; Tyrosinase

Indexed keywords

ASCORBIC ACID; BUTYLATED HYDROXYANISOLE; CATECHOL DERIVATIVE; CHEMICAL AGENT; GLUCOCORTICOID; HYDRAZINE DERIVATIVE; HYDROGEN PEROXIDE; HYDROQUINONE; INDOMETACIN; MONOPHENOL MONOOXYGENASE; PEROXIDASE; SULFANILAMIDE; THIAMAZOLE; THIOL DERIVATIVE;

CYTOTOXICITY; DEPIGMENTATION; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; INHIBITION KINETICS; MELANOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; CATECHOLS; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; MELANINS; MELANOCYTES; MELATONIN; METHIMAZOLE; MONOPHENOL MONOOXYGENASE; PEROXIDASE; SENSITIVITY AND SPECIFICITY;

EID: 0036434140     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066439     Document Type: Review

References (124)

1. Jimbow K, Quevedo WC Jr, Prota G, Fitzpa-trick TB: Biology of melanocytes; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine. New York, McGraw-Hill, 1999, pp 192-219.
2. Sanchez-Ferrer A, Rodriguez-Lopez JN, Garcia-Canovas F, Garcia-Carmona F: Tyrosinase: A comprehensive review of its mechanism. Biochim Biophys Acta 1995;1247:1-11.
3. Okun MR, Donnellan B, Pearson SH, Edelstein LM: Melanin: A normal component of human eosinophils. Lab Invest 1974;30:681-685.
4. Okun MR, Donnellan B, Patel R: Ultrastructural localization of melanin formed by peroxidatic oxidation of tyrosine in neutrophils and eosinophils. Lab Invest 1972;27:151-155.
5. Okun MR: Pigment formation in mast cells in tissue culture. J Invest Dermatol 1967;48:424-428.
6. Okun MR, Edelestein L, Niebauer G, Hamada G: The histochemical tyrosine-dopa reaction for tyrosinase and its use in localizing tyrosinase activity in mast cells. J Invest Dermatol 1969;53:39-45.
7. Okun MR, Edelestein L, Or N, Hamada G, Donnellan B: Histochemical studies of conversion of tyrosine and dopa to melanin mediated by mammalian peroxidase. Life Sci 1970;9: 491-505.
8. Okun MR, Edelestein L, Or N, Hamada G, Donnellan B, Lever W: Histochemical differentiation of peroxidase-mediated from tyrosinase-mediated melanin formation in mammalian tissues. Histochemie 1970;23:295-309.
9. Okun MR, Patel R, Donnellan B, Lever W: Dopa compared with dihydroxyfumarate as cofactor in peroxidase-mediated oxidation of tyrosine to melanin. Histochemie 1971;27:331-334.
10. Okun MR: Peroxidase activity in normal and neoplastic melanocytes. J Invest Dermatol 1967;48:461-465.
11. Okun MR, Schley L, Ziegelstein R, Blair H: Oxidation of tyrosine to dopachrome by perox-idase isolated from murine melanoma. Physiol Chem Phys 1982;14:8-12.
12. Edelestein L, Cariglia N, Okun MR, Patel R, Smucker D: Inability of murine melanoma me-lanosomal 'tyrosinase' (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems. J Invest Dermatol 1975;64:364-370.
13. Okun MR: The role of peroxidase in mammalian melanogenesis: A review. Physiol Chem Phys Med NMR 1996;28:91-101.
14. Holstein TJ, Stowell CP, Quevedo WC Jr, Zarcaro RM, Bienieki TC: Peroxidase, 'protyrosi-nase', and the multiple forms of tyrosinase in mice. Yale J Biol Med 1973;46:560-571.
15. White R, Hu F: Characteristics of tyrosinase in B16 melanoma. J Invest Dermatol 1977;68: 272-276.
16. Smith PI, Swan GA: A study of the supposed hydroxylation of tyrosine catalysed by peroxidase. Biochem J 1976;153:403-408.
17. Mojamdar MV, Sharma KS, Chinoy NJ, Shah VC: Biochemical and histochemical studies on white, brown and black skin regions of the guinea pig. Acta Histochem 1973;6:137-143.
18. Shah VC, Chinoy NJ, Mojamdar MV, Sharma KS: Cytochemical and biochemical study on pigment synthesizing and non-pigment synthesizing skins. Vidya 1973;17:101-110.
19. Chinoy NJ, Mojamdar MV, Sharma KS, Shah VC: Comparative histochemical and biochemical studies on the skin of albino and black rats. Indian J Exp Biol 1973;11:378-381.
20. Mojamdar MV, Shah VC, Chinoy NJ, Sharma KS: Peroxidase dependent oxidation of tyro-sine to melanin in leucoderm vitiliginous skin. Indian J Med Res 1974;62:1720-1724.
21. Van Dujin P: Inactivation experiments on the dopa factor. J Histochem Cytochem 1953;1:143-150.
22. Polis B, Shmukler H: Crystalline lactoperoxidase. J Biol Chem 1953;201:475.
23. Bertazzo A, Costa CV, Allegri G, Favretto D, Traldi P: Application of matrix-assisted laser desorption/ionization mass spectrometry to the detection of melanins formed from Dopa and dopamine. J Mass Spectrom 1999;34:922-929.
24. Mason HS: The chemistry of melanin. III. Mechanism of the oxidation of dihydroxyphe-nylalanine by tyrosinase. J Biol Chem 1948;172:83-99.
25. Korner A, Pawelek J: Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982;217:1163-1165.
26. D'Ischia M, Napolitano A, Prota G: Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydroxyindoles to melanin(s). Biochim Biophys Acta 1991;1073:423-430.
27. Shibata T, Prota G, Mishima Y: Non-melanosomal regulatory factors in melanogenesis. J Invest Dermatol 1993;100:2743-2808.
28. Morgan BDG, O'Neill T, Dewey DL, Galpine AR, Riley PA: Treatment of malignant melano-ma by intravascular 4-hydroxyanisole. Clin Oncol 1981;7:227-234.
29. Inoue S, Hasegawa K, Ito S, Ozeki H, Solano F, Jimenez-Cervantes C, Wakamatsu K, Fujita K: Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol. Cancer Res 1995;55:2603-2607.
30. Jimbow K: N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 1991;127:1528-1534.
31. Bleehen SS, Pathak MA, Hori Y, Fitzpatrick TB: Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds. J Invest Dermatol 1968;50:103-117.
32. Denton CR, Lerner AB, Fitzpatrick TB: Inhibition of melanin formation by chemical agents. J Invest Dermatol 1952;18:119-135.
33. Iijima S, Watanabe K: Studies on dopa reaction. II. Effect of chemicals on the reaction. J Invest Dermatol 1957:28:1-4.
34. Passi S, Nazzaro-Porro M: Molecular basis of substrate and inhibitory specificity of tyrosinase: Phenolic compounds. Br J Dermatol 1981;104:659-665.
35. Ito Y, Jimbow K, Ito S: Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds. J Invest Dermatol 1987;88:77-82.
36. Smith CJ, O'Hare KB, Allen JC: Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res 1988;1:386-389.
37. Dooley TP: Topical skin depigmentation agents: Current products and discovery of novel inhibitors of melanogenesis. J Dermatol Treat 1997;8:275-279.
38. Thomas PD, Kishi H, Cao H, Ota M, Yamashita T, Singh S, Jimbow K: Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs. J Invest Dermatol 1999;113:928-934.
39. Zaumseil RP, Graupe K: Topical azelaic acid in the treatment of melasma: Pharmacologic and clinical considerations; in Castanet J, Frenk E, Gaupe K (eds): Melasma: New Approaches to Treatment. London, Dunitz, 1995, pp 16-40.
40. Nazzaro-Porro M, Passi S: Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 1978;71:205-208.
41. Robins E, Breathnach A, Bashin Y, Ethridge L, Nazzaro-Porro M, Passi S, Picardo M: Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent. J Invest Dermatol 1986;87:293-294.
42. Curto EV, Kwong C, Hermersdorfer H, Glatt H, Santis C, Virador V, Hearing VJ, Dooley TP: Inhibitors of mammalian melanocyte tyrosinase: In vitro comparison of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol 1999;57:663-672.
43. McEwan MT, Parsons PG: Regulation of tyro-sinase expression and activity in human melanoma cells via histamine receptors. J Invest Dermatol 1991;97:868-873.
44. 2) agonist nordimaprit. Biochem Pharmacol 1993;46:47-54.
45. Terao M, Tomita K, Oki T, Tabe L, Gianni M, Garattini E: Inhibition of melanogenesis by BMY-28565, a novel compound depressing tyrosinase activity in B16 melanoma cells. Biochem Pharmacol 1992;43:183-189.
46. Yamada I, Seki S, Ito S, Suzuki S, Matsubara O, Kasuga T: The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines. Br J Cancer 1991;63:187-190.
47. Cooksey CJ, Land EJ, Ramsden CA, Riley PA: Tyrosinase-mediated cytotoxicity of 4-substituted phenols: Quantitative structure-thiol-reactivity relationships of the derived o-quinones. Anticancer Drug Des 1995;10:119-129.
48. Hasegawa K, Ito S, Inoue S, Wakamatsu K, Ozeki H, Ishiguro I: Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol. Biochem Pharmacol 1997;53:1435-1444.
49. Passi S, Picardo M, Nazzaro-Porro M: Comparative cytotoxicity of phenols in vitro. Biochem J 1987;245:537-542.
50. Martinez-Ruiz E, Ortega C, Calduch L, Molina I, Montesinos E, Revert A, Carda C, Navarro V, Jorda E: Generalized cutaneous depigmentation following sulfamide-induced drug eruption. Dermatology 2000;201:252-254.
51. Dunford HB, Adeniran AJ: Hammet rho sigma correlation for reactions of horseradish peroxidase compound II with phenols. Arch Biochem Biophys 1986;251:536-542.
52. Chen H, Eastmond DA: Topoisomerase inhibition by phenolic metabolites: A potential mechanism for benzene's clastogenic effects. Carcinogenesis 1995;16:2301-2307.
53. Thompson DC, Cha YN, Trush MA: The peroxidase-dependent activation of butylated hydroxyanisole and butylated hydroxytoluene (BHT) to reactive intermediates. Formation of BHT-quinone methide via a chemical-chemical interaction. J Biol Chem 1989;264:3957-3965.
54. Paul KG: The enzymes; in Boyer PD, Lardy HA, Myrback K (eds): The Enzymes. New York, Academic Press, 1963, vol 8, pp 227-274.
55. Milstien S, Kaufman S: The oxidation of apomorphine and other catechol compounds by horseradish peroxidase: Relevance to the measurement of dihydropteridine reductase activity. Biochim Biophys Acta 1987;923:333-338.
56. Kalyanaraman B, Sealy RC: Electron spin resonance-spin stabilization in enzymatic systems: Detection of semiquinones produced during peroxidatic oxidation of catechols and catecholamines. Biochem Biophys Res Commun 1982;106:1119-1125.
57. Randall L: Reaction of thiol compounds with peroxidase and hydrogen peroxide. J Biol Chem 1946;164:521-527.
58. Zaton AM, Ochoa de Aspuru E: Horseradish peroxidase inhibition by thiouracils. FEBS Lett 1995;374:192-194.
59. Cuperrus RA, Muijsers AO, Wever R: Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes: A therapeutic mechanism of these drugs in rheumatoid arthritis? Arthritis Rheum 1985;28:1228-1233.
60. Sadler A, Subrahmanyam VV, Ross D: Oxidation of catechol by horseradish peroxidase and human leukocyte peroxidase: Reactions of o-benzoquinone and o-benzosemiquinone. Toxicol Appl Pharmacol 1988;93:62-71.
61. Day BW, Tyurin VA, Tyurina YY, Liu M, Facey JA, Carta G, Kisin ER, Dubey RK, Kagan VE: Peroxidase-catalyzed pro- versus antioxidant effects of 4-hydroxytamoxifen: Enzyme specificity and biochemical sequelae. Chem Res Toxicol 1999;12:28-37.
62. Mayes PA: Biologic oxidation; in Murray RK, Granner DK, Mayes PA, Rodwell VW (eds): Harper's Biochemistry. New York, McGraw-Hill, 2000, pp 130-136.
63. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, Shear NH, Cannon M, Spielberg SP: Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992;51:56-67.
64. Cribb AE, Miller M, Tesoro A, Spielberg SP: Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol Pharmacol 1990;38:744-751.
65. Lai WG, Zahid N, Uetrecht JP: Metabolism of trimethoprim to a reactive iminoquinone methide by activated human neutrophils and hepatic microsomes. J Pharmacol Exp Ther 1999; 291:292-299.
66. Menter JM, Etemadi AA, Chapman W, Hollins TD, Willis I: In vivo depigmentation by hydroxybenzene derivatives. Melanoma Res 1993;3:443-449.
67. Krol ES, Bolton JL: Oxidation of 4-alkylphenols and catechols by tyrosinase: Ortho-substituents alter the mechanism of quinoid formation. Chem Biol Interact 1997;104:11-27.
68. Prezioso JA, Damodaran KM, Wang N, Bloomer WD: Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells. Biochem Pharmacol 1993;45:473-481.
69. Kahn V, Ben-Shalom N: Effect of maltol on the oxidation ofDL-dopa, dopamine, N-acetyldopamine (NADA), and norepinephrine by mushroom tyrosinase. Pigment Cell Res 1997; 10:139-149.
70. Subrahmanyam VV, Kolachana P, Smith MT: Metabolism of hydroquinone by human myeloperoxidase: Mechanisms of stimulation by other phenolic compounds. Arch Biochem Biophys 1991;286:76-84.
71. Garcia-Moreno M, Moreno-Conesa M, Rodriguez-Lopez JN, Garcia-Can F, Varon R: Oxidation of 4-tert-butylcatechol and dopamine by hydrogen peroxide catalysed by horseradish peroxidase. Biol Chem 1999;380:689-694.
72. Josephy PD, Eling TE, Mason RP: Oxidation of p-aminophenol catalyzed by horseradish peroxidase and prostaglandin synthase. Mol Pharmacol 1983;23:461-466.
73. Weller PE, Markey CM, Marnett LJ: Enzymatic reduction of 5-phenyl-4-pentenyl-hydroperoxide: Detection of peroxidases and identification of peroxidase reducing substrates. Arch Biochem Biophys 1985;243:633-643.
74. Lau SS, Hill BA, Highet RJ, Monks TJ: Sequential oxidation and glutathione addition to 1,4-benzoquinone: Correlation of toxicity with increased glutathione substitution. Mol Pharmacol 1988;34:829-836.
75. Mason HS, Spencer E, Yamazaki I: Identification by electron spin resonance spectroscopy of the primary product of tyrosinase catalyzed catechol oxidation. Biochem Biophys Res Commun 1961;4:236-238.
76. Pugh CEM, Raper HS: The action of tyrosinase on phenols: Some observations on the classification of oxidases. Biochem J 1927;21:1370-1383.
77. Jiang Y, Miles PW: Generation of hydrogen peroxide during enzymic oxidation of catechin. Phytochemistry 1993;33:29-34.
78. Gili A, Thomas PD, Ota M, Jimbow K: Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Melanoma Res 2000;10:9-15.
79. Baehner R, Karnovsky ML: Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous diseases. Science 1968;162:1277-1279.
80. Knox WE: The action of peroxidase with enzymically generated peroxide in the presence of catalase. Biochim Biophys Acta 1954;14:117-126.
81. Gillette J, Watland D, Kalnitsky G: The catalysis of the oxidation of some dihydroxybenzene derivatives by various metallic ions. Biochim Biophys Acta 1954;15:526-532.
82. Nappi AJ, Vass E: Hydrogen peroxide generation associated with the oxidations of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Melanoma Res 1996;6:341-349.
83. Ros JR, Rodriguez-Lopez JN, Garcia-Canovas F: Effect ofL-ascorbic acid on the monophenolase activity of tyrosinase. Biochem J 1993;295: 309-312.
84. Nappi AJ, Vass E: Chromatographic analysis of the effects of glutathione, cysteine and ascorbic acid on the monophenol and diphenol oxidase activities of tyrosinase. J Liquid Chromatogr 1994;17:793-815.
85. Williams RN, Paterson CA, Eakins KE, Bhattacherjee P: Ascorbic acid inhibits the activity of polymorphonuclear leukocytes in inflamed ocular tissues. Exp Eye Res 1984;39:261-265.
86. Jacobs JM, Jacobs NJ, Kuhn CB, Gorman N, Dayan FE, Duke SO, Sinclair JF, Sinclair PR: Oxidation of porphyrinogens by horseradish peroxidase and formation of a green pyrrole pigment. Biochem Biophys Res Commun 1996;227:195-199.
87. Rogozhin VV, Verkhoturov VV: Ascorbic acid is a slowly oxidizable substrate of horseradish peroxidase. Biochemistry (Mosc) 1997;62: 1435-1438.
88. Takahama U: Regulation of peroxidase-dependent oxidation of phenolics by ascorbic acid: Different effects of ascorbic acid on the oxidation of coniferyl alcohol by the apoplastic soluble and cell wall bound peroxidases from epicotyls of Vigna angularis. Plant Cell Physiol 1993;34:809-812.
89. Rogozhin VV, Verkhoturov VV: Effect of antioxidants (digoxin, quercetin, and ascorbic acid) on catalytic properties of horseradish peroxidase. Biochemistry 1998;63:657-661.
90. Kligman AM, Willis I: A few formula for depigmenting human skin. Arch Dermatol 1975; 111:40-48.
91. Cahn BI: Leukoderma acquisition: Secondary to intralesional steroid injection. Cutis 1972;9: 509-512.
92. Newman RJ: Local skin depigmentation due to corticosteroid injection. BMJ 1984;288:1725-1726.
93. Chatterjee M, Pal D: Peroxidase enzyme in bursa of Fabricius of chicken and its regulation by dexamethasone. Indian J Exp Biol 1985;23: 682-684.
94. Bandyopadhyay U, Biswas K, Bandyopadhyay D, Ganguly CK, Banerjee RK: Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase - Two important gastroprotective enzymes. Mol Cell Biochem 1999;202:31-36.
95. De SK, Banerjee RK: Glucocorticoid effects on gastric peroxidase activity. Biochim Biophys Acta 1984;800:233-241.
96. De SK, De M, Banerjee RK: Localization and origin of the intestinal peroxidase - Effect of adrenal glucocorticoids. J Steroid Biochem 1986;24:629-635.
97. Ambani M, Van Woert M: Catalase and peroxidase in human brain. Trans Am Neurol 1973;98:7-10.
98. Arnold J, Anthonioz P, Marchand JP: Depigmenting action of corticosteroids: Experimental study on guinea pigs. Dermatologica 1975;151:274-280.
99. Lerner AB, Fitzpatrick TB: Biochemistry of melanin formation. Physiol Rev 1950;30:91-126.
100. 4receptor. Recept Signal Transduc 1996;6:63-75.
101. Alino SF, Hilario E: Effect of indomethacin and acetylsalicylic acid ASA on peroxidase activity of gastric mucosa of rat. Cell Mol Biol 1987;33:29-34.
102. Hsuanyu Y, Dunford HB: Reduction of prostaglandin H synthase compound II by phenol and hydroquinone and the effect of indomethacin. Arch Biochem Biophys 1992;292: 213-220.
103. Takiwaki H, Shirai S, Kohno H, Soh H, Arase S: The degrees of UVB-induced erythema and pigmentation correlate linearly and are reduced in a parallel manner by topical antiinflammatory agents. J Invest Dermatol 1994;103:642-646.
104. Abdel-Malek ZA: Endocrine factors as effectors of integumental pigmentation; in Nordlund J (ed): Dermatologic Clinics. Philadelphia, Saunders Co., 1988, vol 6, pp 175-184.
105. Abdel-Malek ZA, Hadley ME, Bregman MD, Meyskens FL Jr, Hruby VJ: Actions of mela-notropins on mouse melanoma cell growth in vitro. J Natl Cancer Inst 1986;76:857-863.
106. Fourche J, Jensen H, Neuzil E: Interference of hydrazine derivatives with the tyrosinase-tyrosine reaction. C R Acad Sci Hebd Séanc Acad Sci D 1978;287:365-368.
107. Bellegarde B: Alpha-hydrazinophloretic acid, competitive inhibitor of fungal tyrosinase. C R Séanc Acad Sci D 1977;284:2163-2166.
108. Goodwin DC, Grover TA, Aust SD: Roles of efficient substrates in enhancement of peroxidase-catalyzed oxidations. Biochemistry 1997;36:139-147.
109. Degroot LJ: Inhibition of thyroid iodide per-oxidase by hydrazines and NSD-1055 (4-bromo-3-hydroxybenzyl-oxyamine). Endocrinology 1971;88:1264-1266.
110. Blumenkrantz N, Blomstedt L: Chelators depigment and increase elasticity of mink skin. Acta Agricult Scand A Anim Sci 1987;37: 375-396.
111. Lozano JA, Jara JR, Aroca P, Solano F, Martinez JH: The role of sulfhydryl compounds in mammalian melanogenesis: The effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway. Biochim Biophys Acta 1988;967:296-303.
112. Wood JM, Schallreuter KU: Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim Biophys Acta 1991;1074:378-385.
113. Wilson L, Williamson T, Gronowski J, Gentile GJ: Characterization of 4-nitro-o-phenylenediamine activation by plant systems. Mutat Res 1994;307:185-192.
114. Plewa MJ, Smith SR, Wagner ED: Diethyldithiocarbamate suppresses the plant activation of aromatic amines into mutagens by inhibiting tobacco cell peroxidase. Mutat Res 1991;247:57-64.
115. Okun MR, Edelestein LM, Patel RP, Donnellan B: A revised concept of mammalian melanogenesis: The possible synergistic functions of aerobic dopa oxidase and peroxidase: A review. Yale J Biol Med 1973;46:535-540.
116. Davidson B, Soodak M, Strout HV, Neary JT, Nakamura C, Maloof F: Thiourea and cyanamide as inhibitors of thyroid peroxidase: The role of iodide. Endocrinology 1979; 104:919-924.
117. Nagasaka A, Hidaka H: Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodine peroxidase. J Clin Endocrinol Metab 1976; 43:152-158.
118. Kasraee B: Depigmentation of brown guinea pig skin by topical application of methimazole. J Invest Dermatol 2002;118:205-207.
119. Hanlon DP, Shuman S: Cooper ion binding and enzyme inhibitory properties of the antithyroid drug methimazole. Experientia 1975; 31:1005-1006.
120. Borovansky J: Experimental chemotherapy of murine melanomas: Is there a discrepancy compared to clinical experience? Neoplasia J Exp Clin Oncol 1997;44:277-281.
121. Elliott K: Milk peroxidase: Its preparation, properties, and action, with hydrogen peroxide on metabolites. With a method for determining small amounts of hydrogen peroxide in complex mixtures. Biochem J 1932;26:10.
122. Fitzpatrick TB, Szabo G: The melanocyte: Cytology and cytochemistry. J Invest Dermatol 1959;32:197-209.
123. Tobin D, Thody AJ: The superoxide anion may mediate short- but not long-term effects of ultraviolet radiation on melanogenesis. Exp Dermatol 1994;3:99-105.
124. Boekelheide K, Graham DG, Mize PD, Koo EH: Melanocytotoxicity and the mechanism of activation of γ-L-glutaminyl-4-hydroxybenzene. J Invest Dermatol 1980;75:322-327.